Moexipril Hydrochloride (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Moexipril Hydrochloride drug offered from Teva Pharmaceuticals USA Inc. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
| NON-PROPRIETARY NAME: | Moexipril Hydrochloride |
| SUBSTANCE NAME: | MOEXIPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-05-08 |
| END MARKETING DATE: | 0000-00-00 |
Moexipril Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Moexipril Hydrochloride from Teva Pharmaceuticals USA Inc |
| LABELER NAME: | Teva Pharmaceuticals USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.5(mg/1) |
| START MARKETING DATE: | 2003-05-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-0017_5733f525-c05f-4256-bc1d-e1d01610059b |
| PRODUCT NDC: | 0093-0017 |
| APPLICATION NUMBER: | ANDA076204 |
Other MOEXIPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
